Literature DB >> 31694936

Identifying the Cellular Interactome of Epstein-Barr Virus Lytic Regulator Zta Reveals Cellular Targets Contributing to Viral Replication.

Yaqi Zhou1, Kate Heesom2, Kay Osborn1, Rajaei AlMohammed1, Steve M Sweet1, Alison J Sinclair3.   

Abstract

The human gammaherpesvirus Epstein-Barr virus (EBV) (human herpesvirus 4 [HHV4]) infects most adults and is an important contributor to the development of many types of lymphoid and epithelial cancers. Essential contributions of viral genes to viral replication are known, but the potential contributions of cell genes are less well delineated. A key player is the viral protein Zta (BZLF1, ZEBRA, or Z). This sequence-specific DNA-binding protein can disrupt EBV latency by driving the transcription of target genes and by interacting with the EBV lytic origin of replication. Here, we used an unbiased proteomics approach to identify the Zta-interactome in cells derived from Burkitt's lymphoma. Isolating Zta and associated proteins from Burkitt's lymphoma cells undergoing EBV replication, followed by tandem mass tag (TMT) mass spectrometry, resulted in the identification of 39 viral and cellular proteins within the Zta interactome. An association of Zta with the cellular protein NFATc2 was validated in independent experiments. Furthermore, the ability of Zta to attenuate the activity of an NFAT-dependent promoter was shown, which suggests a functional consequence for the association. The expression of Zta is itself regulated through NFAT activity, suggesting that Zta may contribute to a feedback loop that would limit its own expression, thus aiding viral replication by preventing the known toxic effects of Zta overexpression.IMPORTANCE Epstein-Barr virus infects most people across the world and causes several kinds of cancer. Zta is an important viral protein that makes the virus replicate by binding to its DNA and turning on the expression of some genes. We used a sensitive, unbiased approach to isolate and identify viral and cellular proteins that physically interact with Zta. This revealed 39 viral and cellular proteins. We found that one protein, termed NFATc2, was already known to be important for a very early step in viral replication. We identify that once this step has occurred, Zta reduces the effectiveness of NFATc2, and we suggest that this is important to prevent cells from dying before viral replication is complete and the mature virus is released from the cells.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  Epstein-Barr virus; proteomics; transcriptional regulation

Year:  2020        PMID: 31694936      PMCID: PMC7000981          DOI: 10.1128/JVI.00927-19

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

Review 1.  Regulation of the latent-lytic switch in Epstein-Barr virus.

Authors:  Shannon C Kenney; Janet E Mertz
Journal:  Semin Cancer Biol       Date:  2014-01-20       Impact factor: 15.707

2.  Cross-linking of cell surface immunoglobulins induces Epstein-Barr virus in Burkitt lymphoma lines.

Authors:  K Takada
Journal:  Int J Cancer       Date:  1984-01-15       Impact factor: 7.396

3.  Characterization of antigen receptor response elements within the interleukin-2 enhancer.

Authors:  D B Durand; J P Shaw; M R Bush; R E Replogle; R Belagaje; G R Crabtree
Journal:  Mol Cell Biol       Date:  1988-04       Impact factor: 4.272

4.  Functional interaction between Epstein-Barr virus replication protein Zta and host DNA damage response protein 53BP1.

Authors:  Sarah G Bailey; Elizabeth Verrall; Celine Schelcher; Alex Rhie; Aidan J Doherty; Alison J Sinclair
Journal:  J Virol       Date:  2009-08-05       Impact factor: 5.103

5.  Epstein-Barr virus immediate-early protein Zta co-opts mitochondrial single-stranded DNA binding protein to promote viral and inhibit mitochondrial DNA replication.

Authors:  Andreas Wiedmer; Pu Wang; Jing Zhou; Andrew J Rennekamp; Valeria Tiranti; Massimo Zeviani; Paul M Lieberman
Journal:  J Virol       Date:  2008-02-27       Impact factor: 5.103

6.  Cyclosporin A and FK506 block induction of the Epstein-Barr virus lytic cycle by anti-immunoglobulin.

Authors:  A E Goldfeld; P Liu; S Liu; E K Flemington; J L Strominger; S H Speck
Journal:  Virology       Date:  1995-05-10       Impact factor: 3.616

7.  TORC2, a coactivator of cAMP-response element-binding protein, promotes Epstein-Barr virus reactivation from latency through interaction with viral BZLF1 protein.

Authors:  Takayuki Murata; Yoshitaka Sato; Sanae Nakayama; Ayumi Kudoh; Satoko Iwahori; Hiroki Isomura; Masako Tajima; Takayuki Hishiki; Takayuki Ohshima; Makoto Hijikata; Kunitada Shimotohno; Tatsuya Tsurumi
Journal:  J Biol Chem       Date:  2009-01-21       Impact factor: 5.157

8.  CpG-methylation regulates a class of Epstein-Barr virus promoters.

Authors:  Martin Bergbauer; Markus Kalla; Anne Schmeinck; Christine Göbel; Ulrich Rothbauer; Sebastian Eck; Anna Benet-Pagès; Tim M Strom; Wolfgang Hammerschmidt
Journal:  PLoS Pathog       Date:  2010-09-23       Impact factor: 6.823

9.  Unexpected patterns of Epstein-Barr virus transcription revealed by a high throughput PCR array for absolute quantification of viral mRNA.

Authors:  Rosemary J Tierney; Claire D Shannon-Lowe; Leah Fitzsimmons; Andrew I Bell; Martin Rowe
Journal:  Virology       Date:  2014-11-15       Impact factor: 3.616

Review 10.  Epstein-Barr virus-associated lymphomas.

Authors:  Claire Shannon-Lowe; Alan B Rickinson; Andrew I Bell
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-10-19       Impact factor: 6.237

View more
  2 in total

Review 1.  Proteomic approaches to investigate gammaherpesvirus biology and associated tumorigenesis.

Authors:  Danielle L Chappell; Maria C White; Blossom Damania
Journal:  Adv Virus Res       Date:  2020-11-09       Impact factor: 9.937

2.  TMT-based quantitative proteomics analysis reveals the attenuated replication mechanism of Newcastle disease virus caused by nuclear localization signal mutation in viral matrix protein.

Authors:  Zhiqiang Duan; Chao Yuan; Yifan Han; Lei Zhou; Jiafu Zhao; Yong Ruan; Jiaqi Chen; Mengmeng Ni; Xinqin Ji
Journal:  Virulence       Date:  2020-12       Impact factor: 5.882

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.